Regulation of NANOG in Cancer Cells

被引:82
作者
Gong, Shuai [1 ,2 ]
Li, Qiuhui [1 ]
Jeter, Collene R. [1 ]
Fan, Qingxia [2 ]
Tang, Dean G. [1 ,3 ]
Liu, Bigang [1 ]
机构
[1] Univ Texas MD Anderson Canc, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA
[2] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China
[3] Tongji Univ, Sch Med, East Hosp, Canc Stem Cell Inst,Res Ctr Translat Med, Shanghai 200092, Peoples R China
关键词
NANOG; NANOGP8; cancer stem cells; tumor development; EMBRYONIC STEM-CELLS; HUMAN OVARIAN-CANCER; PROSTATE-CANCER; SELF-RENEWAL; POOR-PROGNOSIS; TUMOR PROGRESSION; GENE-EXPRESSION; DOWN-REGULATION; MARKER NANOG; PROTEIN;
D O I
10.1002/mc.22340
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As one of the key pluripotency transcription factors, NANOG plays a critical role in maintaining the self-renewal and pluripotency in normal embryonic stem cells. Recent data indicate that NANOG is expressed in a variety of cancers and its expression correlates with poor survival in cancer patients. Of interest, many studies suggest that NANOG enhances the defined characteristics of cancer stem cells and may thus function as an oncogene to promote carcinogenesis. Therefore, NANOG expression determines the cell fate not only in pluripotent cells but also in cancer cells. Although the regulation of NANOG in normal embryonic stem cells is reasonably well understood, the regulation of NANOG in cancer cells has only emerged recently. The current review provides a most updated summary on how NANOG expression is regulated during tumor development and progression. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:679 / 687
页数:9
相关论文
共 80 条
  • [1] Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance
    Alvero, Ayesha B.
    Chen, Rui
    Fu, Han-Hsuan
    Montagna, Michele
    Schwartz, Peter E.
    Rutherford, Thomas
    Silasi, Dan-Arin
    Steffensen, Karina D.
    Waldstrom, Marianne
    Visintin, Irene
    Mor, Gil
    [J]. CELL CYCLE, 2009, 8 (01) : 158 - 166
  • [2] Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation
    Bagga, S
    Bracht, J
    Hunter, S
    Massirer, K
    Holtz, J
    Eachus, R
    Pasquinelli, AE
    [J]. CELL, 2005, 122 (04) : 553 - 563
  • [3] The DEAH-box helicase DHX36 mediates dendritic localization of the neuronal precursor-microRNA-134
    Bicker, Silvia
    Khudayberdiev, Sharof
    Weiss, Kerstin
    Zocher, Kathleen
    Baumeister, Stefan
    Schratt, Gerhard
    [J]. GENES & DEVELOPMENT, 2013, 27 (09) : 991 - 996
  • [4] Regulatory networks in embryo-derived pluripotent stem cells
    Boiani, M
    Schöler, HR
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (11) : 872 - 884
  • [5] Eleven daughters of NANOG
    Booth, HAF
    Holland, PWH
    [J]. GENOMICS, 2004, 84 (02) : 229 - 238
  • [6] Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells
    Bourguignon, Lilly Y. W.
    Peyrollier, Karine
    Xia, Weiliang
    Gilad, Eli
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (25) : 17635 - 17651
  • [7] NANOG Is Multiply Phosphorylated and Directly Modified by ERK2 and CDK1 In Vitro
    Brumbaugh, Justin
    Russell, Jason D.
    Yu, Pengzhi
    Westphall, Michael S.
    Coon, Joshua J.
    Thomson, James A.
    [J]. STEM CELL REPORTS, 2014, 2 (01): : 18 - 25
  • [8] Identification of a tumor-initiating stem cell population in human renal carcinomas
    Bussolati, Benedetta
    Bruno, Stefania
    Grange, Cristina
    Ferrando, Ugo
    Camussi, Giovanni
    [J]. FASEB JOURNAL, 2008, 22 (10) : 3696 - 3705
  • [9] Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells
    Chambers, I
    Colby, D
    Robertson, M
    Nichols, J
    Lee, S
    Tweedie, S
    Smith, A
    [J]. CELL, 2003, 113 (05) : 643 - 655
  • [10] Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma
    Chiou, Shih-Hwa
    Yu, Cheng-Chia
    Huang, Chi-Yang
    Lin, Shu-Chun
    Liu, Chung-Ji
    Tsai, Tung-Hu
    Chou, Shiu-Huey
    Chien, Chian-Shiu
    Ku, Hung-Hai
    Lo, Jeng-Fan
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4085 - 4095